Asia-pacific Medical Collagen Market Forecast 2022-2030

PUBLISHED: April 30, 2022

PAGES: 165 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

The Asia-Pacific medical collagen market is expected to record a CAGR of 7.00% during the forecast period, 2022-2030. The beauty & personal care industry is booming in the region, and is inclusive of collagen as an ingredient in their face wash, shampoo, and creams, which is vastly accepted by consumers. This is attributed to collagen's beneficial properties.

MARKET INSIGHTS

Taiwan, Australia & New Zealand, Singapore, Indonesia, China, India, South Korea, Japan, and Rest of Asia-Pacific are assessed for the Asia-Pacific medical collagen market growth analysis. Japan is emerging as a lucrative market for collagen products, given their increasing consumption among the female population with regard to keeping the skin young, wrinkle-free, and fresh. Almost every household in Japan has products containing collagen, including shampoos, face masks, and face creams. In addition, the products by the domestic companies are leading the market.

In Indonesia, the increasing use of collagen products has facilitated business expansions among the key market players. For instance, a UK-based company, Collagen Solutions, launched 'ChondroMimetic,' a new product in Indonesia after signing the license and distributor agreement, in 2019. It is a scaffold that is surgically (minimally-invasive) placed for repairing knee cartilage.

In Australia, collagen supplements are increasingly incorporated into diets. Additionally, companies are collaborating to offer optimal products and services for consumers. New Zealand offers lucrative growth opportunities due to the growing popularity of collagen in the country. Moreover, the rising awareness has increased the consumption of collagen in countries like North Korea, Cambodia, Malaysia, Bangladesh, etc.

COMPETITIVE INSIGHTS

Some of the eminent market players include Nippi Inc, Symatese, Stryker, Nitta Gelatin, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 44812

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING AWARENESS
- 3.1.2. GROWING DEMAND FROM MEDICAL DEVICES INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. RESTRICTED DEMANDS DUE TO ANIMAL-BASED PRODUCTS' USE
- 3.2.2. HEALTH-RELATED ISSUES

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON MEDICAL COLLAGEN MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. QUALITY
- 4.7.2. SIDE-EFFECTS
- 4.7.3. PRODUCT EFFECTIVENESS
- 4.7.4. PRICE

5. MARKET BY SOURCE

5.1. BOVINE
5.2. PORCINE
5.3. OTHER SOURCES

6. MARKET BY PRODUCT

6.1. GELATINE
6.2. HYDROLYZED COLLAGEN
6.3. NATIVE COLLAGEN
6.4. OTHER PRODUCTS

7. MARKET BY APPLICATION

7.1. WOUND CARE
7.2. BONE GRAFTS
7.3. TISSUE SCAFFOLDS
7.4. CARTILAGE REPAIR
7.5. HAEMOSTATS
7.6. DIAGNOSTICS
7.7. VASCULAR GRAFTS
7.8. OTHER APPLICATIONS

8. GEOGRAPHICAL ANALYSIS

8.1. ASIA-PACIFIC
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. CHINA
  - 8.1.5.2. JAPAN
  - 8.1.5.3. INDIA
  - 8.1.5.4. SOUTH KOREA
  - 8.1.5.5. INDONESIA
  - 8.1.5.6. TAIWAN
  - 8.1.5.7. SINGAPORE
  - 8.1.5.8. AUSTRALIA & NEW ZEALAND
  - 8.1.5.9. REST OF ASIA-PACIFIC

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. COLLAGEN MATRIX INC
- 9.2.2. CONNOILS LLC
- 9.2.3. DARLING INGREDIENTS INC
- 9.2.4. DSM
- 9.2.5. GELITA
- 9.2.6. INTEGRA LIFESCIENCES
- 9.2.7. ITALGEL
- 9.2.8. JELLAGEN
- 9.2.9. LAPI GELATINE
- 9.2.10. NIPPI INC
- 9.2.11. NITTA GELATIN
- 9.2.12. STRYKER
- 9.2.13. SYMATESE
- 9.2.14. TESSENDERLO
- 9.2.15. WEISHARDT

Product Code: 44812

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MEDICAL COLLAGEN
TABLE 2: SOME MEDICAL APPLICATIONS OF COLLAGEN
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY SOURCE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY SOURCE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: LEADING PLAYERS OPERATING IN ASIA-PACIFIC MEDICAL COLLAGEN MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY SOURCE, IN 2021
FIGURE 8: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY BOVINE, 2022-2030 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY PORCINE, 2022-2030 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER SOURCES, 2022-2030 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 12: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY GELATINE, 2022-2030 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY HYDROLYZED COLLAGEN, 2022-2030 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY NATIVE COLLAGEN, 2022-2030 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER PRODUCTS, 2022-2030 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 17: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY WOUND CARE, 2022-2030 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY BONE GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY TISSUE SCAFFOLDS, 2022-2030 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY CARTILAGE REPAIR, 2022-2030 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY HAEMOSTATS, 2022-2030 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY DIAGNOSTICS, 2022-2030 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY VASCULAR GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC MEDICAL COLLAGEN MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 26: CHINA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: JAPAN MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: INDIA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: SOUTH KOREA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: INDONESIA MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: TAIWAN MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: SINGAPORE MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: REST OF ASIA-PACIFIC MEDICAL COLLAGEN MARKET, 2022-2030 (IN $ MILLION)